News about "Active Pharmaceutical Ingredients "

Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili

Biocon has published pivotal clinical data supporting the effectiveness of Yesafili, its Food and Drug Administration (FDA)-approved interchangeable aflibercept biosimilar, demonstrating comparable safety, efficacy, and immunogenicity.

Active Pharmaceutical Ingredients | 09/07/2026 | By News Bureau |  106

Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis

Sofinnova Partners announced that portfolio company Myricx Bio has agreed to be acquired by Novartis, strengthening the company's oncology pipeline and ADC capabilities.

Active Pharmaceutical Ingredients | 06/07/2026 | By Akanki

DNP Establishes Second Overseas R&D Centre in India at IIT Hyderabad

DNP has established its second overseas R&D base at IIT Hyderabad, India, to accelerate the commercialisation of wireless power supply technologies for Active Pharmaceutical Ingredients (APIs) and Electric Vehicles (EVs), targeting growth opportunities in the Indian and African markets.

Active Pharmaceutical Ingredients | 23/03/2026 | By News Bureau |  124

Piramal Pharma Solutions Commercialises Tablet-in-Capsule Technology at Indian Manufacturing Sites

Piramal Pharma Solutions has successfully developed and commercialised a tablet-in-capsule drug delivery system in India, enabling flexible dosing, dual-release profiles and improved patient-centric oral therapies.

Active Pharmaceutical Ingredients | 03/02/2026 | By News Bureau |  210

ChemWerth Appoints General Sales Manager to Expand API Presence in India

ChemWerth has appointed industry veteran Chandrakanth Reddy as General Sales Manager to drive growth in its generic API business in India, drawing on his 16+ years of experience across multiple global markets.

Active Pharmaceutical Ingredients | 13/01/2026 | By News Bureau |  120

FDA Announces New ANDA Prioritisation Pilot to Support US Generic Drug Manufacturing and Testing

More than half of pharmaceuticals distributed in the US are manufactured overseas. Further, the US is reliant on overseas sources for Active Pharmaceutical Ingredients (APIs). As of 2025, only nine percent of API manufacturers are in the US, compared to 22 percent in China and 44 percent in India.

Active Pharmaceutical Ingredients | 06/10/2025 | By Dineshwori |  178

Supriya Lifescience Secures WHO GMP Certification for Ambernath Facility

The WHO certification for Supriya Lifescience paves way for commercial formulations’ production with INR 500 crore revenue potential.

Active Pharmaceutical Ingredients | 04/10/2025 | By Dineshwori |  565

SwRI Scientists Develop Ion-Assisted Chromatography Process to Accelerate Drug Development

Scientists at Southwest Research Institute have accidently made a discovery of an ion-assisted chromatography process to accelerate drug development.

Active Pharmaceutical Ingredients | 28/08/2025 | By Dineshwori |  191

NATCO Launches Tracleer Generic in US with Lupin

NATCO Pharma has announced the launch of Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc., in partnership with Lupin.

Active Pharmaceutical Ingredients | 20/08/2025 | By Dineshwori |  357

Veranova Names Thomas Rohrer as Vice President of Bioconjugation

Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, has appointed Thomas Rohrer as Vice President of Bioconjugation.

Active Pharmaceutical Ingredients | 29/07/2025 | By Dineshwori |  289